Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Treatment outcomes & life expectancy

How much longer have I got?

News
25 November 2013
The search for a cure

Progress towards an HIV cure

News
25 November 2013
Pharmaceutical industry

Hardly accessible Atripla in Eastern Europe & Central Asia

Editor's pick
EATG / EECA CAB
22 November 2013
Resistance

People who aren't taking HIV treatment are a major source of transmitted resistance in Swiss gay men

News
21 November 2013
Treatment guidelines

Systematic review and meta-analysis shows equivalence of 3TC and FTC

News
20 November 2013
New & experimental HIV treatments

Gilead's Vitekta Gets Approval in European Union

Editor's pick
Wall Street Journal
19 November 2013
Treatment guidelines

BHIVA Autumn Conference: Presentations now available online

Editor's pick
British HIV Association
19 November 2013
Undetectable viral load & treatment as prevention

HIV may be becoming less fit as it adapts to the immune system

News
8 November 2013
Bad science & bogus treatments

South Africa: HIV/Aids holy water cure put to the test

Editor's pick
eNCA
6 November 2013
Government, leadership & policy

Jimmy Carter almost punched Thabo Mbeki

Editor's pick
News 24
4 November 2013
New & experimental HIV treatments

Once-daily raltegravir effective as maintenance therapy

News
31 October 2013
Treatment guidelines

Recommendation on Integrase Inhibitor Use in Antiretroviral Treatment-Naive HIV-Infected Individuals from the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents

Editor's pick
AIDS Info
31 October 2013
Finance & funding

'Early medication for HIV is cost-effective'

Editor's pick
FRANCE 24
31 October 2013
Viral load

HIV rebound linked to higher baseline level, slower suppression and low-level viraemia

News
31 October 2013
Side effects

Differing Effects of Low- and High-Fat Meals on New Raltegravir Formulation

Editor's pick
NATAP
30 October 2013
Government, leadership & policy

WHO and UNAIDS advocate for an initiative to increase access to HIV treatment in the Eastern Mediterranean/Middle East and North Africa regions

Editor's pick
World Health Organization press release
30 October 2013
New & experimental HIV treatments

Dolutegravir matches or surpasses other regimens for first-line HIV treatment

News
30 October 2013
New & experimental HIV treatments

Sangamo BioSciences Presents Clinical Data From HIV Study Demonstrating Sustained Control Of Viremia

Editor's pick
Sangamo press release
29 October 2013
Retention & linkage to care

Social problems and drug and alcohol problems common among people who develop AIDS despite long-term HIV care

News
25 October 2013
HIV testing programmes & uptake

Late testing rates declining in Europe, but largely in gay men

News
24 October 2013
New & experimental HIV treatments

ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine

Editor's pick
Viiv Healthcare
23 October 2013
New & experimental HIV treatments

Future HIV care will include both novel antiretroviral drugs and new treatment strategies

News
22 October 2013
Changing treatment

Once-daily raltegravir for 48 weeks as maintenance therapy in Paris

Editor's pick
NATAP
22 October 2013
Treatment guidelines

Brazil pioneers treatment for everyone

Editor's pick
UNAIDS
21 October 2013